BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38355415)

  • 1. Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure.
    Yu ZL; Cai ZH; Zheng JT; Jiang HY; Zhou YQ; Wong NK; Fu HB; Hong XB
    BMC Cardiovasc Disord; 2024 Feb; 24(1):109. PubMed ID: 38355415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of bedside tissue Doppler echocardiography and B-type natriuretic peptide (BNP) in differentiating congestive heart failure from noncardiac cause of acute dyspnea in elderly patients with a normal left ventricular ejection fraction and permanent, nonvalvular atrial fibrillation: insights from a prospective, monocenter study.
    Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Luccioni R; Ambrosi P
    Echocardiography; 2007 May; 24(5):499-507. PubMed ID: 17456069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.
    Karakiliç E; Kepez A; Abali G; Coşkun F; Kunt M; Tokgözoğlu L
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):143-9. PubMed ID: 20382614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cardiac dyspnea in the emergency department: diagnostic value of N-terminal prohormone of brain natriuretic peptide and galectin-3.
    Stoica A; Şorodoc V; Lionte C; Jaba IM; Costache I; Anisie E; Tuchiluș C; Rusalim Petriș O; Sîrbu O; Jaba E; Ceasovschih A; Vâţă L; Şorodoc L
    J Int Med Res; 2019 Jan; 47(1):159-172. PubMed ID: 30222016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure.
    Song BG; Jeon ES; Kim YH; Kang MK; Doh JH; Kim PH; Ahn SJ; Oh HL; Kim HJ; Sung JD; Lee SC; Gwon HC; Kim JS; Kim DK; Lee SH; Hong KP; Park JE; Lee SY; Lee JK
    Korean J Intern Med; 2005 Mar; 20(1):26-32. PubMed ID: 15906950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.
    Lim TK; Ashrafian H; Dwivedi G; Collinson PO; Senior R
    Eur J Heart Fail; 2006 Jan; 8(1):38-45. PubMed ID: 16115798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction].
    Luo NS; Zhang HF; Liu PM; Lin YQ; Huang TC; Yang Y; Wang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):198-203. PubMed ID: 28316175
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
    Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
    ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
    Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
    Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
    Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 16. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; MacNamara JP; Dias KA; Samels M; Palmer D; Livingston S; Morris M; Levine BD
    Circulation; 2021 Sep; 144(12):934-946. PubMed ID: 34543068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
    Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
    Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
    JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
    Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
    Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.